MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1167/iovs.14-13980

Медицинская библиотека · Investigative ophthalmology & visual science · 2014

Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.

McClintic Scott M, Prajna Namperumalsamy V, Srinivasan Muthiah, Mascarenhas Jeena, Lalitha Prajna, Rajaraman Revathi, Oldenburg Catherine E, O'Brien Kieran S, Ray Kathryn J, Acharya Nisha R, Lietman Thomas M, Keenan Jeremy D

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

PURPOSE: We described the change in visual acuity experienced by eyes successfully treated for bacterial keratitis.

METHODS

This was a prospective cohort study of a subset of study participants who had previously enrolled in the Steroids for Corneal Ulcers Trial (SCUT). All study participants had been diagnosed with culture-proven bacterial keratitis before enrollment in SCUT and subsequently were randomized to adjunctive topical corticosteroids or placebo. During SCUT, we monitored study participants at enrollment, 3 weeks, 3 months, and 12 months. We invited a subset to complete a comprehensive eye examination approximately 4 years after enrollment in SCUT. Certified refractionists assessed best spectacle-corrected visual acuity (BSCVA) using the same protocol at each study visit.

RESULTS

We examined 50 SCUT participants at 4 years after enrollment. Among those in this cohort, mean logMAR BSCVA at enrollment was 0.85 (Snellen equivalent, 20/160; 95% confidence interval [CI], 0.71-0.99). On average, visual acuity improved by 2.9 logMAR lines from enrollment to 3 weeks (P < 0.001), 1.2 lines from 3 weeks to 3 months (P = 0.002), and 0.8 lines from 3 to 12 months (P = 0.01). The BSCVA did not change significantly between 12 months and 4 years (0.04-line improvement, P = 0.88). After controlling for visual acuity at enrollment, BSCVA was not significantly different between the corticosteroid and placebo groups at 4 years (P = 0.53).

CONCLUSIONS

Cases of bacterial keratitis may continue to demonstrate improvements in visual acuity up to 12 months following diagnosis, but further improvements are unlikely. These findings may guide the appropriate timing of surgical intervention in these patients. (ClinicalTrials.gov number, NCT00324168.).

Для цитирования: McClintic Scott M, Prajna Namperumalsamy V, Srinivasan Muthiah, Mascarenhas Jeena, Lalitha Prajna, Rajaraman Revathi, Oldenburg Catherine E, O'Brien Kieran S, Ray Kathryn J, Acharya Nisha R, Lietman Thomas M, Keenan Jeremy D. Visual outcomes in treated bacterial keratitis: four years of prospective follow-up.. Investigative ophthalmology & visual science. 2014. DOI: 10.1167/iovs.14-13980.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.